• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Metabolic Stability Assessed by Liver Microsomes and Hepatocytes

        互联网

        655
        Hepatic metabolism is often a major contributor to drug clearance from the body, highlighting the utility of in vitro liver systems to address chemotypes that undergo extensive metabolism. Drug metabolism can be assessed in a variety of in vitro test systems, including microsomes, cytosol or S9 fractions, hepatocytes (suspension or plated), and isolated liver slices. In drug discovery, metabolic stability is typically determined by measuring the depletion of test compound over time in a relevant in vitro system. Most commonly used in vitro systems are liver microsomes and suspension hepatocytes, which are amenable to automated, high-throughput assay formats. Test compound is quantified in samples using LC/MS/MS, and its metabolic half-life in the in vitro test system is derived from percent remaining vs. time data. Half-life data can be used to rank order compounds according to stability, derive SAR to improve metabolic stability for chemotypes suffering from high turnover, and predict in vivo clearance. The latter is of particular importance to understand in vitro-in vivo correlations and select compounds with appropriate pharmacokinetics in humans. This chapter provides details on the methods used to investigate metabolic stability of test compounds in liver microsomes (for both cytochrome P450s and UDP-glucuronosyltransferases) and in suspension hepatocytes.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序